These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19909830)

  • 1. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.
    Shu M; Liu Q; Wang J; Ao R; Yang C; Fang G; Wan C; Guo W
    Vaccine; 2011 Apr; 29(18):3507-10. PubMed ID: 19909830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on the adverse event following immunization (AEFI) after supplementary immunization activity of measles attenuated live vaccine in Sichuan province in 2007-2008].
    Wang J; Liu QL; Yang CM
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):219-22. PubMed ID: 20084885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Henoch-Schönlein purpura and meningococcal B vaccination.
    Sexton K; McNicholas A; Galloway Y; Radke S; Kieft C; Stehr-Green P; Reid S; Neutze J; Drake R
    Arch Dis Child; 2009 Mar; 94(3):224-6. PubMed ID: 18650242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China.
    Chuang SK; Lau YL; Lim WL; Chow CB; Tsang T; Tse LY
    Bull World Health Organ; 2002; 80(7):585-91. PubMed ID: 12163924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the mass measles vaccination campaign in Guangdong Province, China.
    Peng ZQ; Chen WS; He Q; Peng GW; Wu CG; Xu N; Zhao ZJ; Shu J; Tan Q; Zheng HZ; Lin LF; Deng HH; Lin JY; Zhang YH
    Int J Infect Dis; 2012 Feb; 16(2):e99-103. PubMed ID: 22119269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocytopenic purpura after isolated or combined vaccination against measles, mumps and rubella].
    Autret E; Jonville-Béra AP; Galy-Eyraud C; Hessel L
    Therapie; 1996; 51(6):677-80. PubMed ID: 9164004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles and rubella vaccination of two million Iranians: complications in vaccinees aged 5-25 years.
    Vahdani P; Aminzadeh Z; Alimardani M; Sharafi A
    Scand J Infect Dis; 2005; 37(11-12):913-5. PubMed ID: 16308230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocytopenic purpura following immunization with a live vaccine (mumps-measles-rubella vaccination)?].
    Wiersbitzky S; Bruns R; Schröder C; Warmuth M
    Kinderarztl Prax; 1992 Feb; 60(1):28-9. PubMed ID: 1556850
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
    Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
    Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
    Liu Y; Lin H; Zhu Q; Wu C; Zhao Z; Zheng H
    Vaccine; 2014 Mar; 32(15):1768-73. PubMed ID: 24503272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
    Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measles vaccination and Schönlein-Henoch purpura].
    Mastroiacovo P
    Minerva Pediatr; 1976 Aug; 28(25):1591. PubMed ID: 1004409
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008.
    Khetsuriani N; Imnadze P; Baidoshvili L; Jabidze L; Tatishili N; Kurtsikashvili G; Lezhava T; Laurent E; Martin R
    Vaccine; 2010 Sep; 28(39):6455-62. PubMed ID: 20674880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.